Brief: Allarity Therapeutics On Jan 26 Received Notice From Novartis To Terminate Agreement

Allarity Therapeutics

01/02/2024 22:34

Feb 1 (Reuters) - Allarity Therapeutics Inc  ALLR.O :
    * ALLARITY THERAPEUTICS INC - ON JAN 26 RECEIVED NOTICE FROM
NOVARTIS TO TERMINATE AGREEMENT BASED ON MATERIAL BREACH FOR
LACK OF FINANCIAL PAYMENT
    * ALLARITY THERAPEUTICS INC - TERMINATION TOOK EFFECT ON JAN
26
    * ALLARITY THERAPEUTICS INC - WE AND OUR CONTINUING MEMBERS
OF
BOARD DISAGREE WITH CLAIMS MADE BY JAMES G. CULLEM IN HIS
RESIGNATION EMAIL
    * ALLARITY THERAPEUTICS INC - REMAIN FULLY COMMITTED AND
PRIMARILY
FOCUSED ON OUR PHASE 2 OVARIAN CANCER TRIAL INVOLVING STENOPARIB
    * ALLARITY THERAPEUTICS INC - NOVARTIS TERMINATED AGREEMENT
THAT
PROVIDED CO WITH THE RIGHT TO DOVITINIB

Source text for Eikon:  ID:n0001213900-24-009034 
Further company coverage:  ALLR.O 

 ((Reuters.Briefs@thomsonreuters.com;))